共 96 条
- [1] IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer[J]. CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2538 - 2548Anglesio, Michael S.论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia Univ British Columbia, Dept Pathol, Vancouver, BC, Canada Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaGeorge, Joshy论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaKulbe, Hagen论文数: 0 引用数: 0 h-index: 0机构: Queen Mary Univ London, Barts Canc Inst, Ctr Canc & Inflammat, London, England Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaFriedlander, Michael论文数: 0 引用数: 0 h-index: 0机构: Royal Hosp Women, Dept Med Oncol, Sydney, NSW, Australia Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaRischin, Danny论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaLemech, Charlotte论文数: 0 引用数: 0 h-index: 0机构: Royal Hosp Women, Dept Med Oncol, Sydney, NSW, Australia Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaPower, Jeremy论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaCoward, Jermaine论文数: 0 引用数: 0 h-index: 0机构: Queen Mary Univ London, Barts Canc Inst, Ctr Canc & Inflammat, London, England Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaCowin, Prue A.论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaHouse, Colin M.论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia论文数: 引用数: h-index:机构:Gorringe, Kylie L.论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaCampbell, Ian G.论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaOkamoto, Aikou论文数: 0 引用数: 0 h-index: 0机构: Jikei Univ, Dept Obstet & Gynecol, Sch Med, Tokyo, Japan Jikei Univ, Dept Gene Therapy, Sch Med, Inst DNA Med, Tokyo, Japan Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaBirrer, Michael J.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USA Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaHuntsman, David G.论文数: 0 引用数: 0 h-index: 0机构: Univ British Columbia, Dept Pathol, Vancouver, BC, Canada Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australiade Fazio, Anna论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Westmead Millennium Inst, Westmead Hosp, Westmead Inst Canc Res, Sydney, NSW 2006, Australia Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaKalloger, Steve E.论文数: 0 引用数: 0 h-index: 0机构: Prostate Res Ctr, Genet Pathol Evaluat Ctr, Vancouver, BC, Canada Vancouver Gen Hosp, Dept Pathol, Vancouver, BC V5Z 1M9, Canada Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaBalkwill, Frances论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaGilks, C. Blake论文数: 0 引用数: 0 h-index: 0机构: Univ British Columbia, Dept Pathol, Vancouver, BC, Canada Prostate Res Ctr, Genet Pathol Evaluat Ctr, Vancouver, BC, Canada Vancouver Gen Hosp, Dept Pathol, Vancouver, BC V5Z 1M9, Canada Peter MacCallum Canc Ctr, Melbourne, Vic 8006, AustraliaBowtell, David D.论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia
- [2] The Wnt/β-catenin pathway in ovarian cancer: A review[J]. GYNECOLOGIC ONCOLOGY, 2013, 131 (03) : 772 - 779Arend, Rebecca C.论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35233 USA Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35233 USALondono-Joshi, Angelina I.论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Div Mol & Cellular Pathol, Birmingham, AL 35233 USA Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35233 USAStraughn, J. Michael, Jr.论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35233 USA Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35233 USABuchsbaum, Donald J.论文数: 0 引用数: 0 h-index: 0机构: Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35233 USA Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35233 USA
- [3] Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido[J]. NATURE MEDICINE, 2011, 17 (09) : 1094 - U99Balachandran, Vinod P.论文数: 0 引用数: 0 h-index: 0机构: Mem Hosp, Dept Surg, New York, NY USA Mem Hosp, Dept Surg, New York, NY USACavnar, Michael J.论文数: 0 引用数: 0 h-index: 0机构: Mem Hosp, Dept Surg, New York, NY USA Mem Hosp, Dept Surg, New York, NY USAZeng, Shan论文数: 0 引用数: 0 h-index: 0机构: Mem Hosp, Dept Surg, New York, NY USA Mem Hosp, Dept Surg, New York, NY USABamboat, Zubin M.论文数: 0 引用数: 0 h-index: 0机构: Mem Hosp, Dept Surg, New York, NY USA Mem Hosp, Dept Surg, New York, NY USAOcuin, Lee M.论文数: 0 引用数: 0 h-index: 0机构: Mem Hosp, Dept Surg, New York, NY USA Mem Hosp, Dept Surg, New York, NY USAObaid, Hebroon论文数: 0 引用数: 0 h-index: 0机构: Mem Hosp, Dept Surg, New York, NY USA Mem Hosp, Dept Surg, New York, NY USASorenson, Eric C.论文数: 0 引用数: 0 h-index: 0机构: Mem Hosp, Dept Surg, New York, NY USA Mem Hosp, Dept Surg, New York, NY USAPopow, Rachel论文数: 0 引用数: 0 h-index: 0机构: Mem Hosp, Dept Surg, New York, NY USA Mem Hosp, Dept Surg, New York, NY USAAriyan, Charlotte论文数: 0 引用数: 0 h-index: 0机构: Mem Hosp, Dept Surg, New York, NY USA Mem Hosp, Dept Surg, New York, NY USARossi, Ferdinand论文数: 0 引用数: 0 h-index: 0机构: Sloan Kettering Inst, Dev Biol Program, New York, NY USA Mem Hosp, Dept Surg, New York, NY USABesmer, Peter论文数: 0 引用数: 0 h-index: 0机构: Sloan Kettering Inst, Dev Biol Program, New York, NY USA Mem Hosp, Dept Surg, New York, NY USAGuo, Tianhua论文数: 0 引用数: 0 h-index: 0机构: Mem Hosp, Dept Pathol, New York, NY USA Mem Hosp, Dept Surg, New York, NY USAAntonescu, Cristina R.论文数: 0 引用数: 0 h-index: 0机构: Mem Hosp, Dept Pathol, New York, NY USA Mem Hosp, Dept Surg, New York, NY USATaguchi, Takahiro论文数: 0 引用数: 0 h-index: 0机构: Kochi Univ, Div Human Hlth & Med Sci, Grad Sch Kuroshio Sci, Kochi 780, Japan Mem Hosp, Dept Surg, New York, NY USAYuan, Jianda论文数: 0 引用数: 0 h-index: 0机构: Ludwig Ctr Canc Immunotherapy, New York, NY USA Mem Hosp, Dept Surg, New York, NY USAWolchok, Jedd D.论文数: 0 引用数: 0 h-index: 0机构: Ludwig Ctr Canc Immunotherapy, New York, NY USA Mem Hosp, Dept Med, New York, NY USA Mem Hosp, Dept Surg, New York, NY USAAllison, James P.论文数: 0 引用数: 0 h-index: 0机构: Ludwig Ctr Canc Immunotherapy, New York, NY USA Sloan Kettering Inst, Program Immunol, New York, NY USA Mem Hosp, Dept Surg, New York, NY USADeMatteo, Ronald P.论文数: 0 引用数: 0 h-index: 0机构: Mem Hosp, Dept Surg, New York, NY USA Mem Hosp, Dept Surg, New York, NY USA
- [4] Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (01) : 125 - 130Bendell, Johanna C.论文数: 0 引用数: 0 h-index: 0机构: Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN 37203 USA Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN 37203 USAHong, David S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN 37203 USABurris, Howard A., III论文数: 0 引用数: 0 h-index: 0机构: Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN 37203 USA Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN 37203 USANaing, Aung论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN 37203 USAJones, Suzanne F.论文数: 0 引用数: 0 h-index: 0机构: Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN 37203 USA Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN 37203 USAFalchook, Gerald论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN 37203 USABricmont, Patricia论文数: 0 引用数: 0 h-index: 0机构: Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN 37203 USAElekes, Agnes论文数: 0 引用数: 0 h-index: 0机构: Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN 37203 USARock, Edwin P.论文数: 0 引用数: 0 h-index: 0机构: Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN 37203 USAKurzrock, Razelle论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN 37203 USA
- [5] A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study[J]. ANNALS OF ONCOLOGY, 2011, 22 (02) : 335 - 340Biagi, J. J.论文数: 0 引用数: 0 h-index: 0机构: Canc Ctr S Eastern Ontario, Dept Oncol, Kingston, ON K7L 5P9, Canada Canc Ctr S Eastern Ontario, Dept Oncol, Kingston, ON K7L 5P9, CanadaOza, A. M.论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Hosp, Dept Med, Univ Hlth Network, Toronto, ON M4X 1K9, Canada Canc Ctr S Eastern Ontario, Dept Oncol, Kingston, ON K7L 5P9, CanadaChalChal, H. I.论文数: 0 引用数: 0 h-index: 0机构: Allan Blair Canc Ctr, Dept Med, Regina, SK, Canada Canc Ctr S Eastern Ontario, Dept Oncol, Kingston, ON K7L 5P9, CanadaGrimshaw, R.论文数: 0 引用数: 0 h-index: 0机构: Queen Elizabeth 2 Hlth Sci Ctr, Dept Obstet & Gynecol, Halifax, NS, Canada Canc Ctr S Eastern Ontario, Dept Oncol, Kingston, ON K7L 5P9, CanadaEllard, S. L.论文数: 0 引用数: 0 h-index: 0机构: So Interior Ctr, BC Canc Agcy, Dept Med, Kelowna, BC, Canada Canc Ctr S Eastern Ontario, Dept Oncol, Kingston, ON K7L 5P9, CanadaLee, U.论文数: 0 引用数: 0 h-index: 0机构: Fraser Valley Ctr, Dept Med, Surrey, BC, Canada Fraser Valley Ctr, BC Canc Agcy, Surrey, BC, Canada Canc Ctr S Eastern Ontario, Dept Oncol, Kingston, ON K7L 5P9, CanadaHirte, H.论文数: 0 引用数: 0 h-index: 0机构: Juravinski Canc Ctr, Dept Med, Hamilton, ON, Canada Canc Ctr S Eastern Ontario, Dept Oncol, Kingston, ON K7L 5P9, CanadaSederias, J.论文数: 0 引用数: 0 h-index: 0机构: Queens Univ, Dept Oncol, Kingston, ON, Canada Queens Univ, NCIC Clin Trials Grp, Kingston, ON, Canada Canc Ctr S Eastern Ontario, Dept Oncol, Kingston, ON K7L 5P9, CanadaIvy, S. P.论文数: 0 引用数: 0 h-index: 0机构: NCI, Div Canc Treatment & Diag, Canc Therapy Evaluat Program, Invest Drug Branch, Bethesda, MD 20892 USA Canc Ctr S Eastern Ontario, Dept Oncol, Kingston, ON K7L 5P9, CanadaEisenhauer, E. A.论文数: 0 引用数: 0 h-index: 0机构: Queens Univ, NCIC Clin Trials Grp, Kingston, ON, Canada Canc Ctr S Eastern Ontario, Dept Oncol, Kingston, ON K7L 5P9, Canada
- [6] p38 mitogen-activated protein kinase regulates canonical Wnt-β-catenin signaling by inactivation of GSK3β[J]. JOURNAL OF CELL SCIENCE, 2008, 121 (21) : 3598 - 3607Bikkavilli, Rama Kamesh论文数: 0 引用数: 0 h-index: 0机构: SUNY Stony Brook, Dept Pharmacol, Hlth Sci Ctr, Stony Brook, NY 11794 USA SUNY Stony Brook, Dept Pharmacol, Hlth Sci Ctr, Stony Brook, NY 11794 USAFeigin, Michael E.论文数: 0 引用数: 0 h-index: 0机构: SUNY Stony Brook, Dept Pharmacol, Hlth Sci Ctr, Stony Brook, NY 11794 USA SUNY Stony Brook, Dept Pharmacol, Hlth Sci Ctr, Stony Brook, NY 11794 USAMalbon, Craig C.论文数: 0 引用数: 0 h-index: 0机构: SUNY Stony Brook, Dept Pharmacol, Hlth Sci Ctr, Stony Brook, NY 11794 USA SUNY Stony Brook, Dept Pharmacol, Hlth Sci Ctr, Stony Brook, NY 11794 USA
- [7] Reduction of hypoxia-induced angiogenesis in ovarian cancer cells by inhibition of HIF-1 alpha gene expression[J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2010, 282 (06) : 677 - 683Bryant, Christopher S.论文数: 0 引用数: 0 h-index: 0机构: Wayne State Univ, Barbara Ann Karmanos Canc Inst, Div Gynecol Oncol, Detroit, MI 48201 USA Wayne State Univ, Barbara Ann Karmanos Canc Inst, Div Gynecol Oncol, Detroit, MI 48201 USAMunkarah, Adnan R.论文数: 0 引用数: 0 h-index: 0机构: Henry Ford Hlth Syst, Div Gynecol Oncol, Detroit, MI USA Wayne State Univ, Barbara Ann Karmanos Canc Inst, Div Gynecol Oncol, Detroit, MI 48201 USA论文数: 引用数: h-index:机构:Batchu, Ramesh B.论文数: 0 引用数: 0 h-index: 0机构: Wayne State Univ, Barbara Ann Karmanos Canc Inst, Dept Surg, Detroit, MI 48201 USA Wayne State Univ, Barbara Ann Karmanos Canc Inst, Div Gynecol Oncol, Detroit, MI 48201 USAShah, Jay P.论文数: 0 引用数: 0 h-index: 0机构: Wayne State Univ, Barbara Ann Karmanos Canc Inst, Div Gynecol Oncol, Detroit, MI 48201 USA Wayne State Univ, Barbara Ann Karmanos Canc Inst, Div Gynecol Oncol, Detroit, MI 48201 USABerman, Jeremy论文数: 0 引用数: 0 h-index: 0机构: Wayne State Univ, Barbara Ann Karmanos Canc Inst, Div Gynecol Oncol, Detroit, MI 48201 USA Wayne State Univ, Barbara Ann Karmanos Canc Inst, Div Gynecol Oncol, Detroit, MI 48201 USAMorris, Robert T.论文数: 0 引用数: 0 h-index: 0机构: Wayne State Univ, Barbara Ann Karmanos Canc Inst, Div Gynecol Oncol, Detroit, MI 48201 USA Wayne State Univ, Barbara Ann Karmanos Canc Inst, Div Gynecol Oncol, Detroit, MI 48201 USAJiang, Zhong L.论文数: 0 引用数: 0 h-index: 0机构: Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48201 USA Wayne State Univ, Barbara Ann Karmanos Canc Inst, Div Gynecol Oncol, Detroit, MI 48201 USASaed, Ghassan M.论文数: 0 引用数: 0 h-index: 0机构: Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48201 USA Wayne State Univ, Barbara Ann Karmanos Canc Inst, Div Gynecol Oncol, Detroit, MI 48201 USA
- [8] Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity[J]. MOLECULAR CANCER THERAPEUTICS, 2014, 13 (02) : 364 - 374Campbell, Robert M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAAnderson, Bryan D.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USABrooks, Nathan A.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USABrooks, Harold B.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAChan, Edward M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USADe Dios, Alfonso论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAGilmour, Raymond论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAGraff, Jeremy R.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAJambrina, Enrique论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Alcobendas, Spain Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAMader, Mary论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAMcCann, Denis论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USANa, Songqing论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAParsons, Stephen H.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAPratt, Susan E.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAShih, Chuan论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAStancato, Louis F.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAStarling, James J.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USATate, Courtney论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAVelasco, Juan A.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Alcobendas, Spain Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAWang, Yong论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USAYe, Xiang S.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
- [9] Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4+ Th17 responses to ovarian tumor antigen[J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (05) : 839 - 849Cannon, Martin J.论文数: 0 引用数: 0 h-index: 0机构: Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USAGoyne, Hannah E.论文数: 0 引用数: 0 h-index: 0机构: Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USAStone, Pamela J. B.论文数: 0 引用数: 0 h-index: 0机构: Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USAMacDonald, Laura J.论文数: 0 引用数: 0 h-index: 0机构: Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USAJames, Lindsey E.论文数: 0 引用数: 0 h-index: 0机构: Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USACobos, Everardo论文数: 0 引用数: 0 h-index: 0机构: Texas Tech Univ, Hlth Sci Ctr, Div Hematol & Oncol, Lubbock, TX 79430 USA Southwest Canc Treatment & Res Ctr, Lubbock, TX USA Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USAChiriva-Internati, Maurizio论文数: 0 引用数: 0 h-index: 0机构: Texas Tech Univ, Hlth Sci Ctr, Div Hematol & Oncol, Lubbock, TX 79430 USA Southwest Canc Treatment & Res Ctr, Lubbock, TX USA Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA
- [10] Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity[J]. CANCER CELL, 2013, 24 (06) : 695 - 709Casazza, Andrea论文数: 0 引用数: 0 h-index: 0机构: VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium Katholieke Univ Leuven, Vesalius Res Ctr, Dept Oncol, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, BelgiumLaoui, Damya论文数: 0 引用数: 0 h-index: 0机构: VIB, Lab Myeloid Cell Immunol, B-1050 Brussels, Belgium Vrije Univ Brussel, Dept Mol & Cellular Interact, Lab Cellular & Mol Immunol, B-1050 Brussels, Belgium VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, BelgiumWenes, Mathias论文数: 0 引用数: 0 h-index: 0机构: VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium Katholieke Univ Leuven, Vesalius Res Ctr, Dept Oncol, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, BelgiumRizzolio, Sabrina论文数: 0 引用数: 0 h-index: 0机构: Univ Turin, Dept Oncol, Inst Canc Res Candiolo, I-10060 Turin, Italy VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, BelgiumBassani, Nicklas论文数: 0 引用数: 0 h-index: 0机构: VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium Katholieke Univ Leuven, Vesalius Res Ctr, Dept Oncol, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, BelgiumMambretti, Marco论文数: 0 引用数: 0 h-index: 0机构: VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium Katholieke Univ Leuven, Vesalius Res Ctr, Dept Oncol, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, BelgiumDeschoemaeker, Sofie论文数: 0 引用数: 0 h-index: 0机构: VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium Katholieke Univ Leuven, Vesalius Res Ctr, Dept Oncol, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, BelgiumVan Ginderachter, Jo A.论文数: 0 引用数: 0 h-index: 0机构: VIB, Lab Myeloid Cell Immunol, B-1050 Brussels, Belgium Vrije Univ Brussel, Dept Mol & Cellular Interact, Lab Cellular & Mol Immunol, B-1050 Brussels, Belgium VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, BelgiumTamagnone, Luca论文数: 0 引用数: 0 h-index: 0机构: Univ Turin, Dept Oncol, Inst Canc Res Candiolo, I-10060 Turin, Italy VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, BelgiumMazzone, Massimiliano论文数: 0 引用数: 0 h-index: 0机构: VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium Katholieke Univ Leuven, Vesalius Res Ctr, Dept Oncol, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium